Todd Bazemore - Aug 29, 2025 Form 4 Insider Report for KALA BIO, Inc. (KALA)

Role
President and Chief Executive Officer, Director
Signature
/s/ Mary Reumuth, Attorney-in-Fact
Stock symbol
KALA
Transactions as of
Aug 29, 2025
Transactions value $
$0
Form type
4
Date filed
9/2/2025, 04:08 PM
Previous filing
Jun 26, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bazemore Todd President and Chief Executive Officer, Director C/O KALA BIO, INC., 1167 MASSACHUSETTS AVENUE, ARLINGTON /s/ Mary Reumuth, Attorney-in-Fact 2025-09-02 0001605767

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALA Stock Option (right to buy) Award $0 +180K $0.00 180K Aug 29, 2025 Common Stock 180K $11.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on August 29, 2025 and vests over four years beginning on the vesting commencement date of August 29, 2025, with 1/48th of the shares underlying the option vesting at the end of each successive one-month period thereafter until August 29, 2029, subject to the Reporting Person's continued service.

Remarks:

President and Chief Executive Officer